This article takes a look at a recent FDA warning letter which highlights poor practices in relation to the integrity of electronic data. Broughton Laboratories have invested significantly in computerised systems over the past few years, not only to maintain regulatory compliance but also to provide a system (LabHQ) that add value to our clients.
The full article can be viewed here.
